Public sector Hindustan Latex has firmed up plans to foray in the vaccine segment and will be marketing Hepatitis B and typhoid vaccines in the country. | |
| M Ayyappan, chairman and managing director of the company, said here that the company's plan to venture into the vaccine segment came following "the need to have affordable high-quality vaccines to prevent communicable diseases." |
| |
| He added that it was a public health priority as communicable diseases contributed a significant share of the global burden of disease, particularly in developing nations. |
| |
| The Thiruvananthapuram-headquartered company is all set to don the mini-ratna status any time now, as all the criteria required for the status have been fulfilled, according to Ayyappan. |
| |
| The company, which is among the premier condom manufacturers in the country, is also into manufacture of healthcare products. |
| |
| Adding to its healthcare product range, the company has unveiled a new reuse prevention syringe, brand named Bsure. |
| |
| Ayyappan said, "Bsure has been introduced in partnership with Becton & Dickinson (BD), one of the world's leading healthcare players." |
| |
| PAT at Rs 22.65 cr |
| |
| The company posted a turnover of Rs 213 crore and a profit after tax of Rs 22.65 crore during FY06. |
| |
| Announcing the financial performance of the company here, Ayyappan said that the public sector company aimed at a turnover of Rs 320 crore in the current financial year, which would mean a growth of 50 per cent over the past year. |
| |
| In 2004-05, it posted a turnover of Rs 195 crore and net profit of Rs 20.11 crore. |
| |
